Xconomy: White House Floats Canadian Import Plan But Excludes Many Costly Drugs
The US Department of Health and Human Services says the two proposals are part of the administration’s strategy to curb high prescription-drug prices, which has often been short on action despite the president’s tough rhetoric.
